跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOPORIO 25 MG/250 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DOPORIO 25 MG/250 MG COMPRIMIDOS EFG
Approved
STANDARD
DOPORIO 25 MG/250 MG COMPRIMIDOS EFG
Orion Corporation
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 20, 2024
Approval ID
a165fec243b1064e
Company
Orion Corporation
Type
Standard
Approval Details
Approval Id
a165fec243b1064e
Drug Cima Aemps Name
DOPORIO 25 MG/250 MG COMPRIMIDOS EFG
Register Number
89624
Holder Company Name
Orion Corporation
Marketing Company Name
Orion Pharma S.L.
Holder Company Detail Path
/organization/orion-corporation
Authorization Date
2024-06-20
Dosage Form
COMPRIMIDO
Dose
25 mg/250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
No
Company Name
Orion Corporation
Company Detail Path
/organization/orion-corporation
Company Information
Pharmaceutical Company Name
Orion Corporation
Name En
Orion Corporation (Orion Oyj)
Country Name
Finland
City Name
Espoo
Address
Espoo, Finland
Website
https://www.orionpharma.com
Active Ingredients
LEVODOPA
250 mg
CARBIDOPA MONOHIDRATO
27 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 20, 2024
Approval ID
a165fec243b1064e
Type
Standard
Back to CIMA-AEMPS Approvals